Join the 'Waldenström Macroglobulinemia' group to help and get support from people like you.
Waldenström Macroglobulinemia News
Related terms: Lymphoplasmacytic Lymphoma, WM, Immunocytoma
Posted 8 Sep 2016 by Drugs.com
THURSDAY, Sept. 8, 2016 – Genetically engineered immune cells appear capable of eradicating non-Hodgkin lymphoma when coupled with effective chemotherapy, a new early trial finds. In this experimental therapy, white blood cells known as T-cells are removed from the patient's bloodstream. Then they're genetically modified so they can detect and attack cancerous B-cells, another type of white blood cell in which most types of non-Hodgkin lymphoma occur. One-third of 32 patients treated with the modified T-cells experienced a complete remission of their non-Hodgkin lymphoma. And those pretreated with more aggressive chemotherapy did even better, researchers report. "It's a fantastic step forward," said Susanna Greer, director of clinical research and immunology at the American Cancer Society. "It's been difficult to make a lot of progress in lymphoma, especially in non-Hodgkin lymphoma, ... Read more
Related support groups: Non-Hodgkin's Lymphoma, Follicular Lymphoma, Cutaneous T-cell Lymphoma, Diagnosis and Investigation, Burkitt Lymphoma, Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Mycosis Fungoides, Peripheral T-cell Lymphoma